Guy Goodwin

• Erratum to: Online information seeking by patients with bipolar disorder: results from an international multisite survey.

  Conell J. et al, (2017), Int J Bipolar Disord, 5

• Erratum to "Analysing UK clinicians' understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists" [J. Affect. Disord. 207 (2017) 346-352].

  McAllister-Williams RH. et al, (2017), J Affect Disord, 217, 306 - 307

• Detecting Bipolar Depression From Geographic Location Data.

  Palmius N. et al, (2017), IEEE Trans Biomed Eng, 64, 1761 - 1771

• Antidepressant effect in older depressed patients: the lessons of two agomelatine trials.

  Goodwin GM. et al, (2017), Int Clin Psychopharmacol, 32, 184 - 194

• Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls.

  Smith J. et al, (2017), Mol Psychiatry

• Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.

  Hibar DP. et al, (2017), Mol Psychiatry

• The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment.

  Ashok AH. et al, (2017), Mol Psychiatry, 22, 666 - 679

• The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

  Carhart-Harris RL. and Goodwin GM., (2017), Neuropsychopharmacology

• The experience of gambling problems in British professional footballers: a preliminary qualitative study

  Lim MSM. et al, (2017), Addiction Research and Theory, 25, 129 - 138

• The effects of medication and current mood upon facial emotion recognition: findings from a large bipolar disorder cohort study.

  Bilderbeck AC. et al, (2017), J Psychopharmacol, 31, 320 - 326

• Pharmacological treatment and risk of psychiatric hospital admission in bipolar disorder.

  Joas E. et al, (2017), Br J Psychiatry, 210, 197 - 202

• Experiences of remote mood and activity monitoring in bipolar disorder: A qualitative study.

  Saunders KE. et al, (2017), Eur Psychiatry, 41, 115 - 121

• Analysing UK clinicians' understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists.

  McAllister-Williams RH. et al, (2017), J Affect Disord, 207, 346 - 352

• Subcortical volumetric abnormalities in bipolar disorder.

  Hibar DP. et al, (2016), Mol Psychiatry, 21, 1710 - 1716

• Psilocybin: Psychotherapy or drug?

  Goodwin GM., (2016), J Psychopharmacol, 30, 1201 - 1202

• Online information seeking by patients with bipolar disorder: results from an international multisite survey.

  Conell J. et al, (2016), Int J Bipolar Disord, 4

• Psychoeducation and online mood tracking for patients with bipolar disorder: A randomised controlled trial.

  Bilderbeck AC. et al, (2016), J Affect Disord, 205, 245 - 251

• Daily longitudinal self-monitoring of mood variability in bipolar disorder and borderline personality disorder.

  Tsanas A. et al, (2016), J Affect Disord, 205, 225 - 233

• A specific role for serotonin in overcoming effort cost.

  Meyniel F. et al, (2016), Elife, 5

• Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression: 20 years on.

  Goodwin GM., (2016), J Psychopharmacol, 30, 1090 - 1094

• Bipolar disorder

  Goodwin GM., (2016), Medicine (United Kingdom), 44, 661 - 663

• Associations between mood instability and emotional processing in a large cohort of bipolar patients.

  Bilderbeck AC. et al, (2016), Psychol Med, 46, 3151 - 3160

• Thoughts and acts of self-harm, and suicidal ideation, in online gamblers

  Lloyd J. et al, (2016), International Gambling Studies, 16, 408 - 423

• Internet use by patients with bipolar disorder: Results from an international multisite survey.

  Bauer R. et al, (2016), Psychiatry Res, 242, 388 - 394

• Insensitivity to the Magnitude of Potential Gains or Losses When Making Risky Choices: Women With Borderline Personality Disorder Compared With Bipolar Disorder and Controls.

  Saunders KE. et al, (2016), J Pers Disord, 30, 530 - 544

• Consensus Statement on European Brain Research: the need to expand brain research in Europe - 2015.

  Morris RG. et al, (2016), Eur J Neurosci, 44, 1919 - 1926

• Insomnia and hallucinations in the general population: Findings from the 2000 and 2007 British Psychiatric Morbidity Surveys.

  Sheaves B. et al, (2016), Psychiatry Res, 241, 141 - 146

• Borderline personality disorder, but not euthymic bipolar I disorder, is associated with prolonged post-error slowing in sensorimotor performance.

  Saunders KE. et al, (2016), J Affect Disord, 198, 163 - 170

• Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

  Goodwin GM. et al, (2016), J Psychopharmacol, 30, 495 - 553

• Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.

  Downey D. et al, (2016), Eur Neuropsychopharmacol, 26, 994 - 1003

• The amygdala and fear

  Goodwin GM. and Norbury R., (2016), Stress: Concepts, Cognition, Emotion, and Behavior: Handbook of Stress, 305 - 310

• Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial.

  Saunders KE. et al, (2016), Trials, 17

• Effects of short-term quetiapine treatment on emotional processing, sleep and circadian rhythms.

  Rock PL. et al, (2016), J Psychopharmacol, 30, 273 - 282

• Innovative approaches to bipolar disorder and its treatment.

  Harrison PJ. et al, (2016), Ann N Y Acad Sci, 1366, 76 - 89

• Applications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series.

  Holmes EA. et al, (2016), Transl Psychiatry, 6

• Insomnia, Nightmares, and Chronotype as Markers of Risk for Severe Mental Illness: Results from a Student Population.

  Sheaves B. et al, (2016), Sleep, 39, 173 - 181

• Hippocampal volume in vulnerability and resilience to depression.

  Chan SW. et al, (2016), J Affect Disord, 189, 199 - 202

• Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.

  Geddes JR. et al, (2016), Lancet Psychiatry, 3, 31 - 39

• Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial.

  Yatham LN. et al, (2016), Br J Psychiatry, 208, 78 - 86

• The Safety of Lithium.

  Goodwin GM., (2015), JAMA Psychiatry, 72, 1167 - 1169

• A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.

  Zohar J. et al, (2015), Eur Neuropsychopharmacol, 25, 2318 - 2325

• Bipolar disorder dynamics: affective instabilities, relaxation oscillations and noise.

  Bonsall MB. et al, (2015), J R Soc Interface, 12

• Distinguishing bipolar disorder from borderline personality disorder: A study of current clinical practice.

  Saunders KE. et al, (2015), Eur Psychiatry, 30, 965 - 974

• Gambling problems in bipolar disorder in the UK: prevalence and distribution.

  Jones L. et al, (2015), Br J Psychiatry, 207, 328 - 333

• Vortioxetine reduces BOLD signal during performance of the N-back task in subjects remitted from depression and healthy control participants

  Browning M. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S314 - S315

• The overlap between anxiety, depression, and obsessive-compulsive disorder.

  Goodwin GM., (2015), Dialogues Clin Neurosci, 17, 249 - 260

• Verbal learning impairment in euthymic bipolar disorder: BDI v BDII.

  Bourne C. et al, (2015), J Affect Disord, 182, 95 - 100

• Psychological Effect of an Analogue Traumatic Event Reduced by Sleep Deprivation.

  Porcheret K. et al, (2015), Sleep, 38, 1017 - 1025

• Borderline personality disorder, but not euthymic bipolar disorder, is associated with a failure to sustain reciprocal cooperative behaviour: Implications for spectrum models of mood disorders

  Saunders KEA. et al, (2015), Psychological Medicine, 45, 1591 - 1600

• Rationale and design of OxLith: a randomised placebo controlled trial exploring the short-term physical and psychological effects of lithium on mood instability

  Geddes JR. et al, (2015), BIPOLAR DISORDERS, 17, 110 - 110

• Major depressive disorder: treat the disability, not the diagnosis.

  Goodwin GM., (2015), J Clin Psychiatry, 76, e830 - e831

• Lithium might be associated with better decision-making performance in euthymic bipolar patients.

  Adida M. et al, (2015), Eur Neuropsychopharmacol, 25, 788 - 797

• Depression and violence—what do we really know? – Authors' reply.

  Fazel S. et al, (2015), Lancet Psychiatry, 2

• Daily and weekly mood ratings: relative contributions to the differentiation of bipolar disorder and borderline personality disorder

  Bilderbeck AC. et al, (2015), BIPOLAR DISORDERS, 17, 129 - 130

• Comparative evaluation of quetiapine plus lamotrigine versus quetiapine monotherapy in people with bipolar depression: a randomized trial (CEQUEL)

  Geddes JR. et al, (2015), BIPOLAR DISORDERS, 17, 25 - 25

• Comparative evaluation of quetiapine plus lamotrigine versus quetiapine monotherapy in people with bipolar depression: a randomized trial (CEQUEL)

  Geddes JR. et al, (2015), BIPOLAR DISORDERS, 17, 50 - 51

• Borderline personality disorder, but not euthymic bipolar disorder, is associated with a failure to sustain reciprocal cooperative behaviour: implications for spectrum models of mood disorders.

  Saunders KE. et al, (2015), Psychol Med, 45, 1591 - 1600

• Association between mood variability and emotional processing among individuals diagnosed with bipolar disorder

  Bilderbeck AC. et al, (2015), BIPOLAR DISORDERS, 17, 111 - 111

• Acceptability and tolerability of ambulatory monitoring in bipolar disorder: a patient perspective

  Saunders K. et al, (2015), BIPOLAR DISORDERS, 17, 86 - 86

• Effects of cognitive behavioural therapy for insomnia on the mental health of university students: study protocol for a randomized controlled trial.

  Freeman D. et al, (2015), Trials, 16

• Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.

  Millan MJ. et al, (2015), Eur Neuropsychopharmacol, 25, 599 - 656

• Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders

  Millan MJ. et al, (2015), European Neuropsychopharmacology, 25, 599 - 656

• 60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress

  Millan MJ. et al, (2015), European Neuropsychopharmacology, 25, 591 - 598

• 60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress.

  Millan MJ. et al, (2015), Eur Neuropsychopharmacol, 25, 591 - 598

• Depression and violence: a Swedish population study.

  Fazel S. et al, (2015), Lancet Psychiatry, 2, 224 - 232

• Anomalous emotional processing in depression, and its significance for treatment

  Harmer C. et al, (2015), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 25, S57 - S58

• Public mental health: science or politics?

  Goodwin GM., (2015), World Psychiatry, 14, 3 - 4

• Hypoactivation of the ventral and dorsal striatum during reward and loss anticipation in antipsychotic and mood stabilizer-naive bipolar disorder.

  Yip SW. et al, (2015), Neuropsychopharmacology, 40, 658 - 666

• Letter to the Editor: Comments on 'Is there an excess of significant findings in published studies of psychotherapy for depression?'

  Goodwin GM., (2015), Psychological Medicine, 45

• Lithium might be associated with better decision-making performance in euthymic bipolar patients

  Adida M. et al, (2015), European Neuropsychopharmacology, 25, 788 - 797

• Letter to the Editor: Comments on 'Is there an excess of significant findings in published studies of psychotherapy for depression?'.

  Goodwin GM., (2015), Psychol Med, 45

• Hypoactivation of the ventral and dorsal striatum during reward and loss anticipation in antipsychotic and mood stabilizer-naive bipolar disorder

  Yip SW. et al, (2015), Neuropsychopharmacology, 40, 658 - 666

• Brain imaging in understanding the action of psychotropic drugs: The drugs for depression

  Goodwin GM., (2015), Annales Medico-Psychologiques

• Brain imaging in understanding the action of psychotropic drugs: The drugs for depression

  Goodwin GM., (2015), Annales Medico-Psychologiques, 173, 259 - 262

• Vitamin D deficiency in patients with intellectual disabilities: prevalence, risk factors and management strategies.

  Frighi V. et al, (2014), Br J Psychiatry, 205, 458 - 464

• Pituitary gland volumes in bipolar disorder.

  Clark IA. et al, (2014), J Affect Disord, 169, 197 - 202

• Mood dynamics in bipolar disorder.

  Moore PJ. et al, (2014), Int J Bipolar Disord, 2

• Increased temporo-insular engagement in unmedicated bipolar II disorder: an exploratory resting state study using independent component analysis.

  Yip SW. et al, (2014), Bipolar Disord, 16, 748 - 755

• Hypomanic Experience in Young Adults Confers Vulnerability to Intrusive Imagery After Experimental Trauma: Relevance for Bipolar Disorder.

  Malik A. et al, (2014), Clin Psychol Sci, 2, 675 - 684

• The treatment questions

  Goodwin GM., (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S138 - S138

• From mood stabilisers to channel blockers

  Goodwin GM., (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S151 - S152

• Effects of agomelatine compared to escitalopram on motivation in healthy male and female volunteers after 9 weeks of treatment

  Gaillard R. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S458 - S459

• Better sexual acceptability of agomelatine compared to escitalopram in healthy volunteers during a 9-week placebo-controlled trial

  Montejo AL. et al, (2014), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 24, S454 - S455

• Sleep disturbances and psychotic-like experiences in a student population

  Porcheret K. et al, (2014), JOURNAL OF SLEEP RESEARCH, 23, 234 - 235

• Sleep and circadian rhythms in the bipolar phenotype: a comparison of high-risk individuals defined by hypomania or a family history of affective disorders

  Wulff K. et al, (2014), JOURNAL OF SLEEP RESEARCH, 23, 82 - 82

• Mental imagery in bipolar affective disorder versus unipolar depression: investigating cognitions at times of 'positive' mood.

  Ivins A. et al, (2014), J Affect Disord, 166, 234 - 242

• Economic evaluations in bipolar disorder: a systematic review and critical appraisal.

  Abdul Pari AA. et al, (2014), Bipolar Disord, 16, 557 - 582

• Economic evaluations in bipolar disorder: a systematic review and critical appraisal

  Abdul Pari AAH. et al, (2014), Bipolar disorders, 16, 557 - 582

• Altered plasma glutathione levels in bipolar disorder indicates higher oxidative stress; a possible risk factor for illness onset despite normal brain-derived neurotrophic factor (BDNF) levels.

  Rosa AR. et al, (2014), Psychol Med, 44, 2409 - 2418

• Attacks on antidepressants: signs of deep-seated stigma?

  Nutt DJ. et al, (2014), Lancet Psychiatry, 1, 102 - 104

• The neurocircuitry behind depression

  Goodwin GM., (2014), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 17, 169 - 169

• Risks of all-cause and suicide mortality in mental disorders: a meta-review.

  Chesney E. et al, (2014), World Psychiatry, 13, 153 - 160

• Psychiatric assessment of mood instability: qualitative study of patient experience.

  Bilderbeck AC. et al, (2014), Br J Psychiatry, 204, 234 - 239

• Correlates of depression in bipolar disorder.

  Moore PJ. et al, (2014), Proc Biol Sci, 281

• Correlates of depression in bipolar disorder.

  Moore PJ. et al, (2014), Proceedings. Biological sciences / The Royal Society, 281

• Profil toxique du lithium : revue exhaustive de la littérature avec méta-analyse des résultats

  Adida M. et al, (2014), Annales Medico-Psychologiques

• Lithium toxicity profile: A systematic review and meta-analysis

  Adida M. et al, (2014), Annales Medico-Psychologiques, 172, 212 - 218

• Increased temporo-insular engagement in unmedicated bipolar II disorder: An exploratory resting state study using independent component analysis

  Yip SW. et al, (2014), Bipolar Disorders, 16, 748 - 755

• EFFECTS OF AGOMELATINE AND ESCITALOPRAM ON EMOTIONAL DETACHMENT, EMOTIONAL PROCESSING AND MOTIVATION DURING A 9-WEEK TREATMENT IN HEALTHY VOLUNTEERS

  Goodwin GM. et al, (2014), EUROPEAN PSYCHIATRY, 29

• Cortical glutathione levels in young people with bipolar disorder: A pilot study using magnetic resonance spectroscopy

  Godlewska BR. et al, (2014), Psychopharmacology, 231, 327 - 332

• Cortical glutathione levels in young people with bipolar disorder: a pilot study using magnetic resonance spectroscopy.

  Godlewska BR. et al, (2014), Psychopharmacology (Berl), 231, 327 - 332

• A multi-sensor monitoring system for objective mental health management in resource constrained environments

  Palmius N. et al, (2014), IET Conference Publications, 2014

• Innovative solutions to novel drug development in mental health

  Insel TR. et al, (2013), Neuroscience and Biobehavioral Reviews, 37, 2438 - 2444

• Innovative solutions to novel drug development in mental health.

  Insel TR. et al, (2013), Neurosci Biobehav Rev, 37, 2438 - 2444

• The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.

  Pacchiarotti I. et al, (2013), Am J Psychiatry, 170, 1249 - 1262

• Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial.

  Corruble E. et al, (2013), Int J Neuropsychopharmacol, 16, 2219 - 2234

• Relating mood to plasma glutathione and BDNF levels in patients with bipolar disorder

  Singh N. et al, (2013), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 23, S380 - S380

• Quetiapine's effects on emotional processing and sleep oppose abnormalities seen in bipolar phenotype

  Rock PL. et al, (2013), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 23, S381 - S382

• Short-term quetiapine treatment alters the use of reinforcement signals during risky decision-making and promotes the choice of negative expected values in healthy adult males.

  Rock PL. et al, (2013), J Neurosci, 33, 15588 - 15595

• Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis.

  Bourne C. et al, (2013), Acta Psychiatr Scand, 128, 149 - 162

• Impact of Quetiapine on Emotion Processing, Decision Making and Circadian Rhythms

  Rock PL. et al, (2013), BIOLOGICAL PSYCHIATRY, 73, 160S - 160S

• Combined NK₁ antagonism and serotonin reuptake inhibition: effects on emotional processing in humans.

  Harmer CJ. et al, (2013), J Psychopharmacol, 27, 435 - 443

• The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.

  Grunze H. et al, (2013), World J Biol Psychiatry, 14, 154 - 219

• Relating mood to plasma glutathione and BDNF levels in patients with bipolar disorder

  Singh N. et al, (2013), FASEB JOURNAL, 27

• White matter alterations in antipsychotic- and mood stabilizer-naïve individuals with bipolar II/NOS disorder.

  Yip SW. et al, (2013), Neuroimage Clin, 3, 271 - 278

• New approaches in the treatment of bipolar depression.

  Saunders KE. and Goodwin GM., (2013), Curr Top Behav Neurosci, 14, 291 - 307

• New approaches in the treatment of bipolar depression.

  Saunders KEA. and Goodwin GM., (2013), Curr Top Behav Neurosci, 14, 291 - 307

• Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine.

  Goodwin GM. et al, (2013), Int Clin Psychopharmacol, 28, 20 - 28

• Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine

  Goodwin GM. et al, (2013), International Clinical Psychopharmacology, 28, 20 - 28

• Erratum: Forecasting depression in bipolar disorder (IEEE Transactions on Biomedical Engineering (2012) 59:10 (2801-2807))

  Moore PJ. et al, (2012), IEEE Transactions on Biomedical Engineering, 59

• Revealing the mind's eye: bringing (mental) images into psychiatry.

  Di Simplicio M. et al, (2012), Am J Psychiatry, 169, 1245 - 1246

• Corrections to "forecasting depression in bipolar disorder".

  Moore PJ. et al, (2012), IEEE Trans Biomed Eng, 59

• Bipolar disorder

  Goodwin GM., (2012), Medicine (United Kingdom), 40, 596 - 598

• Contemporary Approaches to Frequent Mood Monitoring in Bipolar Disorder.

  Malik A. et al, (2012), J Exp Psychopathol, 3, 572 - 581

• Forecasting depression in bipolar disorder.

  Moore PJ. et al, (2012), IEEE Trans Biomed Eng, 59, 2801 - 2807

• The Oxford Questionnaire on the Emotional Side-effects of Antidepressants (OQuESA): development, validity, reliability and sensitivity to change.

  Price J. et al, (2012), J Affect Disord, 140, 66 - 74

• The Oxford Questionnaire on the Emotional Side-effects of Antidepressants (OQuESA): Development, validity, reliability and sensitivity to change

  Price J. et al, (2012), Journal of Affective Disorders, 140, 66 - 74

• Reduced subjective response to acute ethanol administration among young men with a broad bipolar phenotype.

  Yip SW. et al, (2012), Neuropsychopharmacology, 37, 1808 - 1815

• Reduced subjective response to acute ethanol administration among young men with a broad bipolar phenotype

  Yip SW. et al, (2012), Neuropsychopharmacology, 37, 1808 - 1815

• Agomelatine: A new insight into antidepressant efficacy

  Goodwin GM., (2012), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 15, 251 - 251

• A Week of Escitalopram Decreases Default Mode Network Activity in Dysphoric and Non-Dysphoric Participants

  Kumar P. et al, (2012), BIOLOGICAL PSYCHIATRY, 71, 199S - 199S

• Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder.

  Bonsall MB. et al, (2012), Proc Biol Sci, 279, 916 - 924

• Facilitated Integrated Mood Management for adults with bipolar disorder.

  Miklowitz DJ. et al, (2012), Bipolar Disord, 14, 185 - 197

• Comparative efficacy of anti-manic drugs in acute mania - Authors' reply

  Cipriani A. et al, (2012), The Lancet, 379

• Lithium toxicity profile: a systematic review and meta-analysis.

  McKnight RF. et al, (2012), Lancet, 379, 721 - 728

• Lithium toxicity profile: A systematic review and meta-analysis

  McKnight RF. et al, (2012), The Lancet, 379, 721 - 728

• Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.

  Baghai TC. et al, (2012), Eur Arch Psychiatry Clin Neurosci, 262, 13 - 22

• Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy.

  Millan MJ. et al, (2012), Nat Rev Drug Discov, 11, 141 - 168

• Management commentary

  Goodwin GM., (2012), Bipolar II Disorder: Modelling, Measuring and Managing, Second Edition, 241 - 244

• Facilitated Integrated Mood Management for adults with bipolar disorder

  Miklowitz DJ. et al, (2012), Bipolar Disorders, 14, 185 - 197

• Bipolar depression and treatment with antidepressants.

  Goodwin GM., (2012), Br J Psychiatry, 200, 5 - 6

• Using an experimental medicine model to explore combination effects of pharmacological and cognitive interventions for depression and anxiety.

  Browning M. et al, (2011), Neuropsychopharmacology, 36, 2689 - 2697

• Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance.

  Goodwin GM. et al, (2011), Curr Med Res Opin, 27, 2285 - 2299

• General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

  Baghai TC. et al, (2011), Eur Arch Psychiatry Clin Neurosci, 261 Suppl 3, 207 - 245

• Foreword

  Robb RA., (2011), Facial Plastic Surgery Clinics of North America, 19

• Cognitions in bipolar affective disorder and unipolar depression: imagining suicide.

  Hales SA. et al, (2011), Bipolar Disord, 13, 651 - 661

• Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis

  Cipriani A. et al, (2011), The Lancet, 378, 1306 - 1315

• Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.

  Cipriani A. et al, (2011), Lancet, 378, 1306 - 1315

• Safety of antipsychotics in people with intellectual disability.

  Frighi V. et al, (2011), Br J Psychiatry, 199, 289 - 295

• Mood stability versus mood instability in bipolar disorder: a possible role for emotional mental imagery.

  Holmes EA. et al, (2011), Behav Res Ther, 49, 707 - 713

• Mood stability versus mood instability in bipolar disorder: A possible role for emotional mental imagery

  Holmes EA. et al, (2011), Behaviour Research and Therapy, 49, 707 - 713

• Symptom relief and facilitation of emotional processing.

  Goodwin GM., (2011), Eur Neuropsychopharmacol, 21 Suppl 4, S710 - S715

• Symptom relief and facilitation of emotional processing

  Goodwin GM., (2011), European Neuropsychopharmacology, 21

• Special issue on CNS experimental medicine.

  Dawson GR. et al, (2011), J Psychopharmacol, 25, 1145 - 1147

• Efficacy markers in depression.

  Harmer CJ. et al, (2011), J Psychopharmacol, 25, 1148 - 1158

• Efficacy markers in depression

  Harmer CJ. et al, (2011), Journal of Psychopharmacology, 25, 1148 - 1158

• Agomelatine facilitates positive versus negative affective processing in healthy volunteer models.

  Harmer CJ. et al, (2011), J Psychopharmacol, 25, 1159 - 1167

• Agomelatine facilitates positive versus negative affective processing in healthy volunteer models

  Harmer CJ. et al, (2011), Journal of Psychopharmacology, 25, 1159 - 1167

• Trait-related decision-making impairment in the three phases of bipolar disorder

  Adida M. et al, (2011), Biological Psychiatry, 70, 357 - 365

• Trait-related decision-making impairment in the three phases of bipolar disorder.

  Adida M. et al, (2011), Biol Psychiatry, 70, 357 - 365

• NEURAL PROCESSING OF EMOTIONAL INFORMATION IS NEGATIVELY BIASED IN DYSPHORIA

  Kumar P. et al, (2011), JOURNAL OF PSYCHOPHARMACOLOGY, 25, A62 - A62

• DISRUPTED NEURAL ACTIVATION IN BIPOLAR PHENOTYPE DURING RISKY DECISION-MAKING

  Rock PL. et al, (2011), JOURNAL OF PSYCHOPHARMACOLOGY, 25, A14 - A14

• Developing a measure of interpretation bias for depressed mood: An ambiguous scenarios test.

  Berna C. et al, (2011), Pers Individ Dif, 51, 349 - 354

• Developing a measure of interpretation bias for depressed mood: An ambiguous scenarios test

  Berna C. et al, (2011), Personality and Individual Differences, 51, 349 - 354

• DECREASED SUBJECTIVE RESPONSE TO ALCOHOL AMONG INDIVIDUALS WITH THE BIPOLAR PHENOTYPE

  Yip SW. et al, (2011), JOURNAL OF PSYCHOPHARMACOLOGY, 25, A13 - A13

• A comprehensive review and model of putative prodromal features of bipolar affective disorder

  Howes OD. et al, (2011), Psychological Medicine, 41, 1567 - 1577

• A comprehensive review and model of putative prodromal features of bipolar affective disorder.

  Howes OD. et al, (2011), Psychol Med, 41, 1567 - 1577

• Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study.

  Kessing LV. et al, (2011), Br J Psychiatry, 199, 57 - 63

• Presence of mental imagery associated with chronic pelvic pain: a pilot study.

  Berna C. et al, (2011), Pain Med, 12, 1086 - 1093

• Presence of Mental Imagery Associated with Chronic Pelvic Pain: A Pilot Study

  Berna C. et al, (2011), Pain Medicine, 12, 1086 - 1093

• Impact of True Colours mood monitoring on mental health service utilisation

  Simon J. et al, (2011), BIPOLAR DISORDERS, 13, 90 - 90

• CEQUEL: A Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy, (and folic acid versus placebo) in people with bipolar depression: a 2x2 factorial randomised trial

  Gardiner A. et al, (2011), BIPOLAR DISORDERS, 13, 21 - 22

• Blood glutathione as a potential biomarker for bipolar disorder

  Goodwin GM. et al, (2011), BIPOLAR DISORDERS, 13, 49 - 49

• What clinical features should determine treatment of Severe Depression?

  Goodwin GM., (2011), INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 15, 23 - 23

• The Effects of Quetiapine on Risky Decision-Making

  Rock PL. et al, (2011), BIOLOGICAL PSYCHIATRY, 69, 237S - 238S

• The diagnostic issue: an updating

  Goodwin GM., (2011), INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 15, 9 - 9

• Burden of Depressive Disorder: unipolar or bipolar?

  Goodwin GM., (2011), INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 15, 22 - 22

• The effects of quetiapine on emotional processing

  Rock PL. et al, (2011), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 21, S60 - S61

• Health economic preparatory work for OXTEXT: The development and evaluation of cost-effective systems of collaborative disease management for people with bipolar disorder.

  Simon J. et al, (2011), The Journal of Mental Health Policy and Economics

• Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders

  Baghai TC. et al, (2011), European Archives of Psychiatry and Clinical Neuroscience, 1 - 10

• Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis

  Cipriani A. et al, (2011), The Lancet

• AGOMELATINE VERSUS ESCITALOPRAM IN MAJOR DEPRESSIVE DISORDERS : A RANDOMIZED DOUBLE-BLIND, LONG TERM STUDY FOCUSING ON SLEEP SATISFACTION AND EMOTIONAL BLUNTING

  Corruble E. et al, (2011), EUROPEAN PSYCHIATRY, 26

• Food Intake and Stress, Human

  Smith K. and Goodwin GM., (2010), 79 - 82

• Fear and the Amygdala

  Norbury R. and Goodwin GM., (2010), 19 - 24

• How psychological symptoms relate to different motivations for gambling: an online study of internet gamblers.

  Lloyd J. et al, (2010), Biol Psychiatry, 68, 733 - 740

• Self-organization in bipolar disorder: Replication of compartmentalization and self-complexity

  Alatiq Y. et al, (2010), Cognitive Therapy and Research, 34, 479 - 486

• How Law 180 in Italy has reshaped psychiatry after 30 years: past attitudes, current trends and unmet needs.

  Altamura AC. and Goodwin GM., (2010), Br J Psychiatry, 197, 261 - 262

• The course of bipolar disorder

  Saunders KEA. and Goodwin GM., (2010), Advances in Psychiatric Treatment, 16, 318 - 328

• The common adolescent bipolar phenotype shows positive biases in emotional processing.

  Rock PL. et al, (2010), Bipolar Disord, 12, 606 - 615

• Internet gamblers: a latent class analysis of their behaviours and health experiences.

  Lloyd J. et al, (2010), J Gambl Stud, 26, 387 - 399

• Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review.

  Fazel S. et al, (2010), Arch Gen Psychiatry, 67, 931 - 938

• THE EFFECTS OF QUETIAPINE ON RISKY DECISION-MAKING

  Rock PL. et al, (2010), JOURNAL OF PSYCHOPHARMACOLOGY, 24, A55 - A55

• New therapeutic strategy in depression. Introduction.

  Goodwin GM., (2010), J Psychopharmacol, 24

• Agomelatine facilitates positive emotional processing in healthy volunteers

  Goodwin GM. et al, (2010), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 20, S379 - S380

• Self-discrepancy in students with bipolar disorder II or NOS.

  Alatiq Y. et al, (2010), J Behav Ther Exp Psychiatry, 41, 135 - 139

• Induction of depressed mood disrupts emotion regulation neurocircuitry and enhances pain unpleasantness.

  Berna C. et al, (2010), Biol Psychiatry, 67, 1083 - 1090

• Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.

  Miskowiak KW. et al, (2010), Psychopharmacology (Berl), 210, 419 - 428

• 5-HT(1A) receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-(11)C]WAY-100635.

  Sargent PA. et al, (2010), J Affect Disord, 123, 77 - 80

• Lateral prefrontal cortex mediates the cognitive modification of attentional bias.

  Browning M. et al, (2010), Biol Psychiatry, 67, 919 - 925

• Thought suppression in patients with bipolar disorder.

  Miklowitz DJ. et al, (2010), J Abnorm Psychol, 119, 355 - 365

• The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study.

  Bopp JM. et al, (2010), Bipolar Disord, 12, 327 - 334

• Hypomanic Experience is Associated with Increased dlPFC and ACC Activity to Socially-Threatening Words

  Rock PL. et al, (2010), BIOLOGICAL PSYCHIATRY, 67, 146S - 146S

• Dysfunctional beliefs in bipolar disorder: hypomanic vs. depressive attitudes.

  Alatiq Y. et al, (2010), J Affect Disord, 122, 294 - 300

• Drs. Harmer, Goodwin, and Cowen reply

  Harmer CJ. et al, (2010), American Journal of Psychiatry, 167, 599 - 600

• Do Antidepressants Alter Emotional Processing in PTSD? Reply

  Harmer CJ. et al, (2010), AMERICAN JOURNAL OF PSYCHIATRY, 167, 599 - 600

• NK1 receptor antagonism and emotional processing in healthy volunteers.

  Chandra P. et al, (2010), J Psychopharmacol, 24, 481 - 487

• The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.

  Grunze H. et al, (2010), World J Biol Psychiatry, 11, 81 - 109

• The International Society for Bipolar Disorders (ISBD) Task Force on the Nomenclature of Course and Outcome in Bipolar Disorders

  Tohen M. et al, (2010), BIPOLAR DISORDERS, 12, 53 - 53

• Students scoring highly on the mood disorder questionnaire show increased dorsolateral prefrontal cortex (DLPFC) activity to threatening words

  Rock PL. et al, (2010), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 20, S94 - S95

• Key issues in bipolar disorder: a global survey of patients, carers, and health care professionals

  Berk M. et al, (2010), BIPOLAR DISORDERS, 12, 8 - 9

• Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.

  BALANCE investigators and collaborators None. et al, (2010), Lancet, 375, 385 - 395

• Internet Gamblers: A Latent Class Analysis of Their Behaviours and Health Experiences

  Lloyd J. et al, (2010), Journal of Gambling Studies, 1 - 13

• Induction of Depressed Mood Disrupts Emotion Regulation Neurocircuitry and Enhances Pain Unpleasantness

  Berna C. et al, (2010), Biological Psychiatry

• AGOMELATINE, THE FIRST MELATONERGIC ANTIDEPRESSANT: A SUSTAINED EFFICACY IN SEVERELY DEPRESSED PATIENTS

  Montgomery SA. et al, (2010), EUROPEAN PSYCHIATRY, 25

• A Pilot Study of Mindfulness-Based Cognitive Therapy for Bipolar Disorder

  Miklowitz DJ. et al, (2009), INTERNATIONAL JOURNAL OF COGNITIVE THERAPY, 2, 373 - 382

• Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.

  Miskowiak KW. et al, (2009), Psychopharmacology (Berl), 207, 133 - 142

• Altered risk-aversion and risk-seeking behavior in bipolar disorder.

  Chandler RA. et al, (2009), Biol Psychiatry, 66, 840 - 846

• A novel scale for measuring mixed states in bipolar disorder.

  Cavanagh J. et al, (2009), Clin Psychol Psychother, 16, 497 - 509

• Reduced limbic connections may contraindicate subgenual cingulate deep brain stimulation for intractable depression.

  McNab JA. et al, (2009), J Neurosurg, 111, 780 - 784

• Effect of acute antidepressant administration on negative affective bias in depressed patients.

  Harmer CJ. et al, (2009), Am J Psychiatry, 166, 1178 - 1184

• Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients

  Miskowiak K. et al, (2009), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 19, S189 - S190

• Emotional side-effects of selective serotonin reuptake inhibitors (SSRIs): qualitative study

  Price J. et al, (2009), British Journal of Psychiatry, 195, 211 - 217

• Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study.

  Price J. et al, (2009), Br J Psychiatry, 195, 211 - 217

• Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action.

  Harmer CJ. et al, (2009), Br J Psychiatry, 195, 102 - 108

• The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.

  Tohen M. et al, (2009), Bipolar Disord, 11, 453 - 473

• Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.

  Goodwin GM. et al, (2009), J Clin Psychiatry, 70, 1128 - 1137

• Treatment nonadherence and neurocognitive impairment in bipolar disorder.

  Martinez-Aran A. et al, (2009), J Clin Psychiatry, 70, 1017 - 1023

• The effects of the active treatment Run-in Phase on the BALANCE Trial

  Rendell JM. et al, (2009), BIPOLAR DISORDERS, 11, 71 - 72

• Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.

  Goodwin GM. and Consensus Group of the British Association for Psychopharmacology None., (2009), J Psychopharmacol, 23, 346 - 388

• Does mental imagery act as an emotional amplifier in Bipolar Disorder? Initial findings for a catalyst of mood instability

  Holmes EA. et al, (2009), BIPOLAR DISORDERS, 11, 47 - 48

• Differences in deliberation and processing of reward in bipolar disorders

  Chandler RA. et al, (2009), BIPOLAR DISORDERS, 11, 28 - 28

• A UK consensus on the administration of aripiprazole for the treatment of mania.

  Aitchison KJ. et al, (2009), J Psychopharmacol, 23, 231 - 240

• Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele.

  Filippini N. et al, (2009), Proc Natl Acad Sci U S A, 106, 7209 - 7214

• Learning to Look on the Bright Side: The Neural Consequences of an Induced Attentional Bias

  Browning M. et al, (2009), BIOLOGICAL PSYCHIATRY, 65, 84S - 84S

• Bipolar anxiety.

  Goodwin GM. and Holmes EA., (2009), Rev Psiquiatr Salud Ment, 2, 95 - 98

• P.3.11 Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients

  Miskowiak KW. et al, (2009), European Neuropsychopharmacology, 19

• Risk for depression and neural responses to fearful facial expressions of emotion.

  Chan SW. et al, (2009), Br J Psychiatry, 194, 139 - 145

• Effectiveness as an outcome measure for treatment trials in psychiatry.

  Fleischhacker WW. and Goodwin GM., (2009), World Psychiatry, 8, 23 - 27

• The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.

  Grunze H. et al, (2009), World J Biol Psychiatry, 10, 85 - 116

• Survey of furan in foods and coffees from five European Union countries.

  Crews C. et al, (2009), Food Addit Contam Part B Surveill, 2, 95 - 98

• Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.

  Geddes JR. et al, (2009), Br J Psychiatry, 194, 4 - 9

• Clinical studies on the efficacy of agomelatine on depressive symptoms.

  Goodwin GM., (2009), CNS Drugs, 23 Suppl 2, 35 - 39

• The European College of Neuropsychopharmacology consensus statement on bipolar depression

  Goodwin GM., (2008), Giornale di Neuropsicofarmacologia, 30

• Mental imagery as an emotional amplifier: application to bipolar disorder.

  Holmes EA. et al, (2008), Behav Res Ther, 46, 1251 - 1258

• The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study.

  Norbury R. et al, (2008), Mol Psychiatry, 13, 1011 - 1020

• Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.

  Tohen M. et al, (2008), J Clin Psychiatry, 69, 1776 - 1789

• Lack of insight may predict impaired decision making in manic patients.

  Adida M. et al, (2008), Bipolar Disord, 10, 829 - 837

• Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report.

  Goodwin GM. et al, (2008), Eur Neuropsychopharmacol, 18, 787 - 793

• Risk for depression is associated with neural biases in emotional categorisation.

  Chan SW. et al, (2008), Neuropsychologia, 46, 2896 - 2903

• Major depression is sometimes described as the common cold of psychiatry.

  Goodwin GM., (2008), J Psychopharmacol, 22

• Innovation translates into antidepressant effectiveness.

  Goodwin GM., (2008), J Psychopharmacol, 22, 9 - 12

• Perceptual switch rates with ambiguous structure-from-motion figures in bipolar disorder.

  Krug K. et al, (2008), Proc Biol Sci, 275, 1839 - 1848

• Long-term treatment with agomelatine: prevention of relapse in patients with Major Depressive Disorder over 10 months

  Goodwin GM. et al, (2008), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 18, S338 - S339

• ECNP consensus meeting. Bipolar depression. Nice, March 2007.

  Goodwin GM. et al, (2008), Eur Neuropsychopharmacol, 18, 535 - 549

• A new US-UK diagnostic project: mood elevation and depression in first-year undergraduates at Oxford and Stanford universities.

  Chandler RA. et al, (2008), Acta Psychiatr Scand, 118, 81 - 85

• Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients.

  Gorwood P. et al, (2008), Am J Psychiatry, 165, 731 - 739

• Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning.

  Williams JM. et al, (2008), J Affect Disord, 107, 275 - 279

• The emerging physical health challenges of antipsychotic associated hyperprolactinaemia in patients with serious mental illness.

  Dursun SM. et al, (2008), J Psychopharmacol, 22, 3 - 5

• Equilibrium - The bipolar foundation, and the international bipolar disorder survey. Who are we are and what are we doing?

  Ogilvie AD. et al, (2008), JOURNAL OF AFFECTIVE DISORDERS, 107, S61 - S61

• Common and specific elements of psychosocial treatments for bipolar disorder: a survey of clinicians participating in randomized trials.

  Miklowitz DJ. et al, (2008), J Psychiatr Pract, 14, 77 - 85

• International aspects of bipolar disorder results from a major international survey of more than 2600 people

  Ogilvie AD. et al, (2008), BIPOLAR DISORDERS, 10, 10 - 10

• Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.

  Miskowiak K. et al, (2008), Neuropsychopharmacology, 33, 611 - 618

• Diagnostic guidelines for bipolar depression: a probabilistic approach.

  Mitchell PB. et al, (2008), Bipolar Disord, 10, 144 - 152

• Are neuropsycholgical measures of bipolarity and outcome the way forward for improved treatment?

  Goodwin GM., (2008), BIPOLAR DISORDERS, 10, 27 - 27

• Management commentary

  Goodwin GM., (2008), Bipolar II Disorder: Modelling, Measuring and Managing, 262 - 264

• Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.

  Miskowiak K. et al, (2008), Exp Brain Res, 184, 313 - 321

• The cognitive neuropsychology of depression in the elderly.

  Herrmann LL. et al, (2007), Psychol Med, 37, 1693 - 1702

• The rise and fall of mood stabilizers.

  Malhi GS. and Goodwin GM., (2007), Aust N Z J Psychiatry, 41, 779 - 783

• Long-term efficacy of agomelatine, a novel antidepressant, in the prevention of relapse in out-patients with major depressive disorder

  Goodwin GM. et al, (2007), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 17, S361 - S362

• What is the heartland of psychiatry?

  Goodwin GM. and Geddes JR., (2007), Br J Psychiatry, 191, 189 - 191

• Single dose antidepressant administration modulates the neural processing of self-referent personality trait words.

  Miskowiak K. et al, (2007), Neuroimage, 37, 904 - 911

• Reply to Low-Dose Tryptophan Depletion

  Cowen PJ. et al, (2007), Biological Psychiatry, 62, 543 - 544

• Highly neurotic never-depressed students have negative biases in information processing.

  Chan SW. et al, (2007), Psychol Med, 37, 1281 - 1291

• Bipolar disorder: the neglected psychosis

  Bhagwagar Z. and Goodwin GM., (2007), Psychiatry, 6, 389 - 392

• A single dose of citalopram increases fear recognition in healthy subjects.

  Browning M. et al, (2007), J Psychopharmacol, 21, 684 - 690

• Quetiapine more effective than placebo for depression in bipolar I and II disorder.

  Goodwin GM., (2007), Evid Based Ment Health, 10

• Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study.

  Norbury R. et al, (2007), Br J Psychiatry, 190, 531 - 532

• International perspectives: England

  Goodwin GM., (2007), BIPOLAR DISORDERS, 9, 5 - 5

• What is a mood stabilizer?

  Goodwin GM. and Malhi GS., (2007), Psychol Med, 37, 609 - 614

• Bipolar comorbidity, neurobiology and clinical presentation

  Goodwin GM., (2007), International Journal of Psychiatry in Clinical Practice, 11

• Exploring the physiological effects of double-cone coil TMS over the medial frontal cortex on the anterior cingulate cortex: an H2(15)O PET study.

  Hayward G. et al, (2007), Eur J Neurosci, 25, 2224 - 2233

• Bipolar disorder update

  Goodwin GM., (2007), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 17, S131 - S131

• Effective management of depressed mood with agomelatine, a melatonergic antidepressant

  Goodwin GM., (2007), EUROPEAN PSYCHIATRY, 22, S91 - S91

• Bipolar disorder

  Geddes JR. and Briess D., (2007), BMJ clinical evidence, 2007

• Role of the primary care physician in bipolar disorder

  Tylee A. and Goodwin GM., (2006), Primary Care Mental Health, 4, 221 - 233

• Aromatase inhibitors and bipolar mood disorder: a case report.

  Goodwin GM., (2006), Bipolar Disord, 8, 516 - 518

• Understanding the symptom continuum from depression to suicide

  Goodwin GM., (2006), BIPOLAR DISORDERS, 8, 8 - 8

• Deep brain stimulation for psychiatric disorders, an emerging therapy

  Aziz TZ. and Goodwin GM., (2006), BIPOLAR DISORDERS, 8, 12 - 12

• Bipolar disorder - The heartland of psychiatry

  Goodwin GM., (2006), BIPOLAR DISORDERS, 8, 10 - 10

• Antidepressant drug treatment modifies the neural processing of nonconscious threat cues.

  Harmer CJ. et al, (2006), Biol Psychiatry, 59, 816 - 820

• 5HT(3) antagonism abolishes the emotion potentiated startle effect in humans.

  Harmer CJ. et al, (2006), Psychopharmacology (Berl), 186, 18 - 24

• Suicide trends in discharged patients with mood disorders: associations with selective serotonin uptake inhibitors and comorbid substance misuse.

  Fazel S. et al, (2006), Int Clin Psychopharmacol, 21, 111 - 115

• Risperidone alone or in combination for acute mania.

  Rendell JM. et al, (2006), Cochrane Database Syst Rev

• Long-term prophylaxis in bipolar disorder.

  Taylor MJ. and Goodwin GM., (2006), CNS Drugs, 20, 303 - 310

• Depression and associated physical diseases and symptoms.

  Goodwin GM., (2006), Dialogues Clin Neurosci, 8, 259 - 265

• Exploring the endophenotype in bipolar disorder

  Goodwin GM., (2005), NEUROPSYCHOPHARMACOLOGY, 30, S21 - S22

• Impairment of executive function but not memory in first-degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression (vol 162, pg 1980, 2005)

  Clark L. et al, (2005), AMERICAN JOURNAL OF PSYCHIATRY, 162, 2205 - 2205

• Evidence Based Medicine: Principles and application to bipolar disorder

  Goodwin GM., (2005), Annales Medico-Psychologiques, 163, 753 - 757

• What outcomes, what interventions - the methodology

  Goodwin GM., (2005), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 15, S333 - S334

• Impairment of executive function but not memory in first-degree relatives of patients with bipolar I disorder and in euthymic patients with unipolar depression.

  Clark L. et al, (2005), Am J Psychiatry, 162, 1980 - 1982

• Between the poles: new strategies for the treatment of acute bipolar mania

  Goodwin GM., (2005), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 15, S662 - S663

• Overnight administration of a branched chain amino acid (BCAA) mixture

  Scarna A. et al, (2005), JOURNAL OF PSYCHOPHARMACOLOGY, 19, A35 - A35

• Does tryptophan supplementation induce similar changes in emotional processing to an SSRI?

  Murphy SE. et al, (2005), JOURNAL OF PSYCHOPHARMACOLOGY, 19, A49 - A49

• Acute antidepressant administration modulates the neural processing of positive versus negative self-referent personality characteristics

  Miskowiak K. et al, (2005), JOURNAL OF PSYCHOPHARMACOLOGY, 19, A54 - A54

• Optimizing clinical management of bipolar disorder: Translating science into practice

  Goodwin GM., (2005), Bipolar Disorders, Supplement, 7

• Antidepressants for bipolar depression - Dr. Gijsman and colleagues reply

  Gijsman HJ. et al, (2005), AMERICAN JOURNAL OF PSYCHIATRY, 162, 1547 - 1548

• Antidepressants for bipolar depression.

  Ghaemi SN. and Goodwin FK., (2005), Am J Psychiatry, 162, 1545 - 1546

• Lamotrigine in the treatment of bipolar disorder.

  Bhagwagar Z. and Goodwin GM., (2005), Expert Opin Pharmacother, 6, 1401 - 1408

• The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision-making.

  Scarnà A. et al, (2005), Psychopharmacology (Berl), 179, 761 - 768

• Enhanced early morning salivary cortisol in neuroticism.

  Portella MJ. et al, (2005), Am J Psychiatry, 162, 807 - 809

• Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms.

  Hayward G. et al, (2005), Biol Psychiatry, 57, 517 - 524

• Bipolar disorder

  Goodwin GM., (2005), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 15, S71 - S72

• Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression.

  Clark L. et al, (2005), Biol Psychiatry, 57, 183 - 187

• The burden on informal caregivers of people with bipolar disorder.

  Ogilvie AD. et al, (2005), Bipolar Disord, 7 Suppl 1, 25 - 32

• Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems.

  Harvey AG. et al, (2005), Am J Psychiatry, 162, 50 - 57

• Mood stabilizers: a labile label.

  Malhi GS. et al, (2005), Acta Psychiatr Scand Suppl, 5 - 6

• Lithium - a continuing story in the treatment of bipolar disorder.

  Carney SM. and Goodwin GM., (2005), Acta Psychiatr Scand Suppl, 7 - 12

• Characterizing barriers, challenges and unmet needs in the management of bipolar disorder.

  Chengappa KR. and Goodwin GM., (2005), Bipolar Disord, 7 Suppl 1, 5 - 7

• Cognitive neuroscience and bipolar disorder: Mechanisms of drug action and relevant outcomes

  Goodwin GM., (2004), NEUROPSYCHOPHARMACOLOGY, 29, S12 - S13

• Approaches to the management of bipolar disorder: past, present and future.

  Goodwin GM., (2004), Expert Rev Neurother, 4 Suppl 1, S1 - S2

• Bipolar disorder: the neglected psychosis

  Bhagwagar Z. and Goodwin GM., (2004), Psychiatry, 3, 67 - 70

• Neuroticism as a psychological vulnerability factor for mood disorders

  Portella MJ. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A12 - A12

• Neuroendocrine and neuropsychological effects of a branched chain amino acid (BCAA) mixture supplemented with tryptophan

  Scama A. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A47 - A47

• Elevated waking cortisol levels in neuroticism: A biological vulnerability factor for depressive disorders?

  Portella MJ. et al, (2004), JOURNAL OF PSYCHOPHARMACOLOGY, 18, A11 - A11

• Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.

  Gijsman HJ. et al, (2004), Am J Psychiatry, 161, 1537 - 1547

• Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.

  Harmer CJ. et al, (2004), Am J Psychiatry, 161, 1256 - 1263

• When does a "new" mood stabilizer replace an "old" mood stabilizer?

  Goodwin GM., (2004), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 7, S53 - S53

• Long term treatment management of bipolar disease

  Goodwin GM., (2004), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 7, S129 - S129

• Introduction to systematic reviews.

  Goodwin GM. and Geddes JR., (2004), J Psychopharmacol, 18, 249 - 250

• Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials.

  Taylor MJ. et al, (2004), J Psychopharmacol, 18, 251 - 256

• European Neuropsychopharmacology: Foreword

  Goodwin GM., (2004), European Neuropsychopharmacology, 14

• State- and trait-related deficits in sustained attention in bipolar disorder.

  Clark L. and Goodwin GM., (2004), Eur Arch Psychiatry Clin Neurosci, 254, 61 - 68

• Developing the BALANCE trial - the role of the pilot study and start-up phase (vol 6, pg 26, 2004)

  Rendell JM. et al, (2004), BIPOLAR DISORDERS, 6, 170 - 170

• A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

  Goodwin GM. et al, (2004), J Clin Psychiatry, 65, 432 - 441

• The role of the anterior cingulate cortex in the counting Stroop task.

  Hayward G. et al, (2004), Exp Brain Res, 154, 355 - 358

• Relapse into mania or depression following lithium discontinuation: a 7-year follow-up.

  Cavanagh J. et al, (2004), Acta Psychiatr Scand, 109, 91 - 95

• Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.

  Geddes JR. et al, (2004), Am J Psychiatry, 161, 217 - 222

• Developing the BALANCE trail--the role of the pilot study and start-up phase.

  Rendell JM. et al, (2004), Bipolar Disord, 6, 26 - 31

• The neurobiology of bipolar disorder

  Goodwin GM., (2004), BIPOLAR DISORDERS, 6, 11 - 11

• The effects of lithium and lamotrigine in prevention of relapse/recurrence of bipolar I depression

  Yatham L. et al, (2004), BIPOLAR DISORDERS, 6, 28 - 28

• Optimizing treatment to prevent relapse

  Goodwin GM., (2004), BIPOLAR DISORDERS, 6, 13 - 13

• Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression.

  Bhagwagar Z. et al, (2004), Am J Psychiatry, 161, 166 - 168

• Lamotrigine and lithium as maintenance treatment for bipolar I disorder

  Yatham L. et al, (2004), BIPOLAR DISORDERS, 6, 33 - 33

• Bipolar-spectrum disorders: An epidemic unseen, invisible or unreal?

  Bhagwagar Z. and Goodwin GM., (2004), Advances in Psychiatric Treatment, 10, 1 - 3

• The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: a summary.

  Goodwin GM. and Young AH., (2003), J Psychopharmacol, 17, 3 - 6

• An introduction to the British Association for Psychopharmacology guidelines: Evidence-based treatment of bipolar affective disorder

  Goodwin GM. and Young AH., (2003), Journal of Psychopharmacology, 17, 1 - 2

• Effects of antidepressants on emotional processing

  Harmer CJ. et al, (2003), JOURNAL OF PSYCHOPHARMACOLOGY, 17, A1 - A1

• Does depression influence symptom severity in irritable bowel syndrome? Case study of a patient with irritable bowel syndrome and bipolar disorder.

  Crane C. et al, (2003), Psychosom Med, 65, 919 - 923

• Latest maintenance data on lithium in bipolar disorder.

  Goodwin GM. and Geddes JR., (2003), Eur Neuropsychopharmacol, 13 Suppl 2, S51 - S55

• Tryptophan depletion decreases the recognition of fear in female volunteers.

  Harmer CJ. et al, (2003), Psychopharmacology (Berl), 167, 411 - 417

• Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.

  Goodwin GM. and Consensus Group of the British Association for Psychopharmacology None., (2003), J Psychopharmacol, 17, 149 - 173

• Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity.

  Harmer CJ. et al, (2003), Am J Psychiatry, 160, 990 - 992

• Effects of a branched-chain amino acid drink in mania.

  Scarna A. et al, (2003), Br J Psychiatry, 182, 210 - 213

• Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review.

  Geddes JR. et al, (2003), Lancet, 361, 653 - 661

• Olanzapine alone or in combination for acute mania.

  Rendell JM. et al, (2003), Cochrane Database Syst Rev

• Discussion to 'Sex differences in the hypothalamus in the different stages of human life' by Dick E Swaab et al.

  Pfaff DW. et al, (2003), NEUROBIOLOGY OF AGING, 24, S17 - S19

• Discussion to 'Imaging methods for evaluating brain function in man' by Robert M. Kessler

  Finch CE. et al, (2003), NEUROBIOLOGY OF AGING, 24, S37 - S39

• Antidepressants and emotional processing

  Harmer CJ. et al, (2003), Neuropsychopharmacology, 28, 1384 - 1385

• Acute SSRI administration affects the processing of social cues in healthy volunteers.

  Harmer CJ. et al, (2003), Neuropsychopharmacology, 28, 148 - 152

• The role of lithium in the treatment of bipolar depression

  Bhagwagar Z. and Goodwin GM., (2002), Clinical Neuroscience Research, 2, 222 - 227

• Cerebellar responses during anticipation of noxious stimuli in subjects recovered from depression. Functional magnetic resonance imaging study.

  Smith KA. et al, (2002), Br J Psychiatry, 181, 411 - 415

• The effects of dietary tyrosine depletion by a branch chain amino acid mixture in acutely manic patients

  Scarna A. et al, (2002), JOURNAL OF PSYCHOPHARMACOLOGY, 16, A45 - A45

• Repeated administration of citalopram or reboxetine reduces the perception of negative emotions from facial expression.

  Harmer CJ. et al, (2002), JOURNAL OF PSYCHOPHARMACOLOGY, 16, A41 - A41

• Repeated administration of citalopram or reboxetine reduces the perception of negative emotions from facial expression.

  Harmer CJ. et al, (2002), JOURNAL OF PSYCHOPHARMACOLOGY, 16, A70 - A70

• Low frequency medial frontal TMS does not have antidepressant properties in a single treatment session

  Hayward GN. et al, (2002), JOURNAL OF PSYCHOPHARMACOLOGY, 16, A43 - A43

• Acute administration of citalopram facilitates memory consolidation in healthy volunteers

  Harmer CJ. et al, (2002), JOURNAL OF PSYCHOPHARMACOLOGY, 16, A27 - A27

• A novel scale for measuring mixed states in bipolar disorder

  Cavanagh JTO. et al, (2002), JOURNAL OF PSYCHOPHARMACOLOGY, 16, A45 - A45

• Acute administration of citalopram facilitates memory consolidation in healthy volunteers.

  Harmer CJ. et al, (2002), Psychopharmacology (Berl), 163, 106 - 110

• Chronic, treatment-resistant depression and right fronto-striatal atrophy.

  Shah PJ. et al, (2002), Br J Psychiatry, 180, 434 - 440

• Sustained attention deficit in bipolar disorder.

  Clark L. et al, (2002), Br J Psychiatry, 180, 313 - 319

• Role of mood stabilizers in bipolar disorder.

  Bhagwagar Z. and Goodwin GM., (2002), Expert Rev Neurother, 2, 239 - 248

• A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function.

  Gijsman HJ. et al, (2002), Psychopharmacology (Berl), 160, 192 - 197

• Enhanced recognition of disgust in bipolar illness.

  Harmer CJ. et al, (2002), Biol Psychiatry, 51, 298 - 304

• BALANCE: a large simple trial of maintenance treatment for bipolar disorder.

  Geddes JR. et al, (2002), World Psychiatry, 1, 48 - 51

• Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise.

  Harmer CJ. et al, (2002), Neuropsychologia, 40, 1586 - 1590

• Effect of branch chain amino acids supplemented with tryptophan on tyrosine availability and plasma prolactin.

  Scarnà A. et al, (2002), Psychopharmacology (Berl), 159, 222 - 223

• Gender differences in the relationship between personality dimensions and relative body weight.

  Faith MS. et al, (2001), Obes Res, 9, 647 - 650

• Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness.

  McTavish SF. et al, (2001), Br J Psychiatry, 179, 356 - 360

• A neuropsychological investigation of prefrontal cortex involvement in acute mania.

  Clark L. et al, (2001), Am J Psychiatry, 158, 1605 - 1611

• The addition of folic acid to fluoxetine for major depression increased response rates especially in women: COMMENTARY

  Goodwin GM., (2001), Evidence-Based Mental Health, 4

• Administration of the beta-adrenoceptor blocker propranolol impairs the processing of facial expressions of sadness.

  Harmer CJ. et al, (2001), Psychopharmacology (Berl), 154, 383 - 389

• The influence of positive and negative mood states on risk taking, verbal fluency, and salivary cortisol.

  Clark L. et al, (2001), J Affect Disord, 63, 179 - 187

• High and low neuroticism predict different cortisol responses to the combined dexamethasone--CRH test.

  McCleery JM. and Goodwin GM., (2001), Biol Psychiatry, 49, 410 - 415

• Cognitive deficits in depression: possible implications for functional neuropathology.

  Austin MP. et al, (2001), Br J Psychiatry, 178, 200 - 206

• Tyrosine depletion attenuates dopamine function in healthy volunteers.

  Harmer CJ. et al, (2001), Psychopharmacology (Berl), 154, 105 - 111

• Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

  Macritchie KA. et al, (2001), Cochrane Database Syst Rev

• Transcranial magnetic stimulation of medial-frontal cortex impairs the processing of angry facial expressions.

  Harmer CJ. et al, (2001), Nat Neurosci, 4, 17 - 18

• Repetitive transcranial magnetic stimulation to right prefrontal cortex does not modulate the psychostimulant effects of amphetamine.

  Clark L. et al, (2000), Int J Neuropsychopharmacol, 3, 297 - 302

• Chronic fatigue syndrome and depression.

  Goudsmit E., (2000), Br J Psychiatry, 177

• Chronic fatigue syndrome and depression - Reply

  MacHale SM. et al, (2000), BRITISH JOURNAL OF PSYCHIATRY, 177, 470 - 470

• Bipolar disorder: is psychiatry's Cinderella starting to get out a little more?

  Goodwin GM., (2000), Acta Neuropsychiatr, 12

• Review: Lower doses of antidepressant drugs are effective and have fewer adverse effects in depression. Commentary

  Goodwin GM., (2000), Evidence-Based Medicine, 5

• Cerebral perfusion in chronic fatigue syndrome and depression.

  MacHale SM. et al, (2000), Br J Psychiatry, 176, 550 - 556

• The difference in patterns of motor and cognitive function in chronic fatigue syndrome and severe depressive illness.

  Lawrie SM. et al, (2000), Psychol Med, 30, 433 - 442

• Modelling a loss event: effect of imagined bereavement on the hypothalamic-pituitary-adrenal axis.

  McCleery JM. et al, (2000), Psychol Med, 30, 219 - 223

• The split-dose technique for the study of psychological and pharmacological activation with the cerebral blood flow marker 99m-Tc-exametazime and single photon emission computed tomography (SPECT): reproducibility and rater reliability

  Ebmeier KP. et al, (1991), International Journal of Methods in Psychiatric Research, 1, 27 - 38

• Oxford Lithium Trial (OxLith): a randomised, double-blind placebo-controlled study of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorde

  Geddes JR. et al, Trials

Recent Publications

• Erratum to: Online information seeking by patients with bipolar disorder: results from an international multisite survey.

  Conell J. et al, (2017), Int J Bipolar Disord, 5

• Erratum to "Analysing UK clinicians' understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists" [J. Affect. Disord. 207 (2017) 346-352].

  McAllister-Williams RH. et al, (2017), J Affect Disord, 217, 306 - 307

• Detecting Bipolar Depression From Geographic Location Data.

  Palmius N. et al, (2017), IEEE Trans Biomed Eng, 64, 1761 - 1771

• Antidepressant effect in older depressed patients: the lessons of two agomelatine trials.

  Goodwin GM. et al, (2017), Int Clin Psychopharmacol, 32, 184 - 194

• Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls.

  Smith J. et al, (2017), Mol Psychiatry